A Phase II Study of Breast Cancer Treatment Using Weekly Carboplatin + Paclitaxel with Pertuzumab + Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting

UCI-14-67
NCT02436993
Cancer - Breast - Female
Rita Mehta
Open
Treatment
Avastin, Bevacizumab, Carboplatin, Herceptin, Paclitaxel, Paraplatin, Pertuzumab, Taxol, Trastuzumab
II
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.